KNE.V
Kane Biotech Inc
Price:
0.05
CAD
Volume:
439,300
Canada | Biotechnology
KNE.V ROE (Return on Equity)
As of 2025-07-20, the ROE (Return on Equity) of Kane Biotech Inc (KNE.V) is -374.3%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
KNE.V ROE (Return on Equity) - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | -374.3% |
| 2023-12-31 | 47.7% |
| 2022-12-31 | 59.6% |
| 2021-12-31 | 118.5% |
| 2020-12-31 | 258.2% |
| 2019-12-31 | -114.7% |
| 2018-12-31 | 331.1% |
| 2017-12-31 | -160.2% |
| 2016-12-31 | -189.1% |
| 2015-12-31 | -356.1% |
KNE.V ROE (Return on Equity) - Peers Comparison